Midgard Science

Labs / Assays & in vitro testing

D

Desentum

Espoo, Finland · desentum.fi

GMP

Desentum is a research-oriented clinical-stage biopharmaceutical company in Espoo, Finland. It develops allergen immunotherapy products for aeroallergens and food allergens, with lead programs in birch pollen, peanut, and cat allergy. The company works on recombinant hypoallergens designed for subcutaneous allergen immunotherapy.

They take quote requests by email.

What they offer

  • Allergen immunotherapy product development

    Develops novel allergen immunotherapy products intended to change immune response from hypersensitivity to tolerance.

  • Recombinant hypoallergen design

    Creates recombinant allergens with targeted modifications to reduce IgE cross-linking while retaining native conformation.

  • Controlled-release formulation development

    Develops a formulation for controlled release of the active substance after injection.

  • Clinical development of investigational allergy treatments

    Advances lead assets such as DM-101PX in clinical development for birch pollen allergy.

  • Preclinical development of allergy candidates

    Develops hypoallergens for allergies including peanut, grass pollen, and cat allergy in preclinical development.

What they work on

Modalities
Antibody, Peptide
Therapeutic areas
allergies, birch pollen allergy, peanut allergy, cat allergy, grass pollen allergy
Sites
Espoo, Finland
Founded
2011

Public records

Ownership
Desentum Oy · FI GLEIF

Similar labs. Bioneeds, Biofidus GmbH, EyeCRO, JPT Peptide Technologies

Found in a contract services directory. Listing built from desentum.fi. Work here? Claim this listing.

Desentum · Midgard Science